Related Experiment Video
Updated: Aug 8, 2025

06:58
Rapid Homogeneous Detection of Biological Assays Using Magnetic Modulation Biosensing System
Published on: June 13, 2010
9.7K
Highly Sensitive Magnetoelastic Biosensor for Alpha2-Macroglobulin Detection Based on MnFe2O4@chitosan/MWCNTs/PDMS
Xing Guo1,2, Jianru Hou1,2, Yang Ge1,2
1Shanxi Key Laboratory of Micro Nano Sensors & Artificial Intelligence Perception, College of Information and Computer, Taiyuan University of Technology, Taiyuan 030024, China.
Micromachines
|February 25, 2023
Summary
A novel biosensor detects Alpha2-Macroglobulin (α2-M) for diabetic nephropathy (DN) diagnosis. This fast, sensitive, and portable sensor offers a new tool for early disease detection and point-of-care applications.
Area of Science:
- Biomedical Engineering
- Materials Science
- Analytical Chemistry
Background:
- Alpha2-Macroglobulin (α2-M) is crucial for diagnosing diabetic nephropathy (DN).
- Existing sensors lack the sensitivity, speed, and portability required for effective α2-M detection.
- There is a need for advanced biosensing technologies for early DN diagnosis.
Purpose of the Study:
- To develop a highly sensitive, rapid, flexible, and portable biosensor for detecting α2-M.
- To utilize a MnFe2O4@chitosan/MWCNTs/PDMS composite film for enhanced biosensing capabilities.
- To provide a novel method for the early diagnosis of diabetic nephropathy.
Main Methods:
- Fabrication of a composite film biosensor using MnFe2O4 nanoparticles, chitosan, MWCNTs, and PDMS.
- Utilizing the magnetoelastic effect of MnFe2O4 for signal transduction upon antibody-antigen binding.
- Employing chitosan for simplified biological modification and MWCNTs for enhanced conductivity and sensitivity.
Main Results:
- The biosensor demonstrated a low limit of detection (LOD) of 0.1299 ng·mL⁻¹ for α2-M.
- Achieved a wide linear detection range from 10 ng·mL⁻¹ to 100 µg·mL⁻¹.
- The sensor exhibited rapid, highly sensitive, and selective detection of α2-M.
Conclusions:
- The developed biosensor offers a novel and effective method for the early diagnosis of diabetic nephropathy.
- The biosensor's characteristics make it suitable for point-of-care (PoC) applications.
- This technology advances α2-M detection, addressing limitations of current diagnostic tools.

